Selenium and vitamin E for prostate cancer--justifications for the SELECT study.

Area of Science:

• Oncology
• Nutritional Science
• Preventive Medicine

Background:

• Oxidative damage is implicated in cancer development.
• Antioxidants like selenium and vitamin E have shown potential in reducing prostate cancer risk in some studies.

Purpose of the Study:

• To evaluate the efficacy of selenium and vitamin E supplementation in preventing prostate cancer.

Main Methods:

• The Selenium and Vitamin E Cancer Prevention Trial (SELECT) was a large-scale, long-duration study with stringent conditions and standardized analyses.
• Utilized a large sample size and robust experimental design for high external validity.

Main Results:

• The SELECT study found no significant reduction in prostate cancer risk associated with selenium and vitamin E supplementation.
• Conflicting results have led to debates regarding study methodology, supplement types, and dosage assessment.

Conclusions:

• Despite previous hypotheses, the SELECT trial did not support selenium and vitamin E supplementation for prostate cancer prevention.
• Further investigation into the mechanisms behind these results and the search for novel preventive agents are recommended.